HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C L Slingluff Selected Research

C L Slingluff Research Topics

Disease

11Melanoma (Melanoma, Malignant)
01/2017 - 01/2000
7Neoplasms (Cancer)
06/2001 - 03/2000
2Neoplasm Metastasis (Metastasis)
10/2001 - 03/2001
1Tetanus
10/2001
1Lobular Carcinoma
06/2000
1Margins of Excision
06/2000
1Vaccinia
04/2000

Drug/Important Bio-Agent (IBA)

7Peptides (Polypeptides)IBA
11/2001 - 01/2000
5EpitopesIBA
11/2001 - 01/2000
4VaccinesIBA
10/2001 - 03/2000
3HLA-A2 Antigen (HLA A2 Antigen)IBA
06/2001 - 03/2000
3HLA-A3 Antigen (HLA A3 Antigen)IBA
06/2001 - 04/2000
2Protein Subunit VaccinesIBA
01/2017 - 06/2001
2AntigensIBA
11/2001 - 03/2000
2gp100(280-288) melanoma antigen peptideIBA
10/2001 - 06/2001
2Monatide (IMS 3015)IBA
10/2001 - 06/2001
2Monophenol Monooxygenase (Tyrosinase)IBA
06/2001 - 03/2000
2gp100(17-25) peptideIBA
06/2001 - 03/2001
2HLA-A1 Antigen (HLA A1 Antigen)IBA
06/2001 - 03/2000
2Melanoma-Specific AntigensIBA
03/2001 - 03/2000
2Cancer VaccinesIBA
03/2000 - 03/2000
1saponin QA-21V1 (QS21)IBA
10/2001
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
10/2001
1CytokinesIBA
10/2001
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
10/2001
1EmulsionsIBA
06/2001
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2001
1Neoplasm Antigens (Tumor Antigens)IBA
03/2001
1Interferon alpha-2 (Roferon-A)FDA Link
02/2001
1Proteins (Proteins, Gene)FDA Link
03/2000
1HLA-A Antigens (HLA-A)IBA
03/2000
1MART-1 AntigenIBA
01/2000

Therapy/Procedure

2Immunotherapy
04/2000 - 03/2000
1Segmental Mastectomy (Lumpectomy)
06/2000